Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.95
+0.51 (4.46%)
Jul 27, 2026, 4:00 PM EDT - Market closed

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
9491,185556529465600
Market Cap Growth
58.65%112.96%5.12%13.75%-22.47%-36.65%
Enterprise Value
1,3161,267461.01286.9406.97508.24
Last Close Price
11.9516.598.129.1311.2219.67

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.636.7710.07776.05--
PB Ratio
--2.70-2.19-7.27-6.228.32
P/TBV Ratio
-----10.09

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
6.427.238.34420.68--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.49-0.48-0.79-1.90-1.291.26
Net Debt / Equity Ratio
0.04-0.190.383.330.78-1.27
Net Debt / EBITDA Ratio
0.15-0.510.351.450.340.68
Net Debt / FCF Ratio
0.15-0.490.361.740.400.62
Asset Turnover
0.730.550.140.0000
Inventory Turnover
5.135.183.610.28--
Quick Ratio
2.091.583.929.885.929.69
Current Ratio
2.211.734.2010.256.129.86
Return on Equity (ROE)
40.59%63.97%204.90%273.21%14877.60%-108.01%
Return on Assets (ROA)
-34.24%-50.19%-70.05%-57.83%-97.36%-55.76%
Return on Invested Capital (ROIC)
-321.78%-646.28%-1549.19%-1511.26%-4106.69%-1805.64%
Return on Capital Employed (ROCE)
-62.89%-76.24%-83.12%-65.15%-111.58%-65.88%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-13.31%-15.42%-23.18%-31.11%-5.72%-11.36%
Total Shareholder Return
-13.31%-15.42%-23.18%-31.11%-5.72%-11.36%
SEC Filings: 10-K · 10-Q